BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31362847)

  • 1. A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance.
    Alsowat D; Zak M; McCoy B; Kabir N; Al-Mehmadi S; Chan V; Whitney R
    Pediatr Neurol; 2020 Jan; 102():44-48. PubMed ID: 31362847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
    Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
    Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
    Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
    Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
    Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
    Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
    de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
    J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
    Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
    Northrup H; Aronow ME; Bebin EM; Bissler J; Darling TN; de Vries PJ; Frost MD; Fuchs Z; Gosnell ES; Gupta N; Jansen AC; Jóźwiak S; Kingswood JC; Knilans TK; McCormack FX; Pounders A; Roberds SL; Rodriguez-Buritica DF; Roth J; Sampson JR; Sparagana S; Thiele EA; Weiner HL; Wheless JW; Towbin AJ; Krueger DA;
    Pediatr Neurol; 2021 Oct; 123():50-66. PubMed ID: 34399110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
    de Vries PJ; Whittemore VH; Leclezio L; Byars AW; Dunn D; Ess KC; Hook D; King BH; Sahin M; Jansen A
    Pediatr Neurol; 2015 Jan; 52(1):25-35. PubMed ID: 25532776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.
    Ebrahimi-Fakhari D; Hussong J; Flotats-Bastardas M; Ebrahimi-Fakhari D; Zemlin M; von Gontard A; Meyer S
    Neuropediatrics; 2019 Oct; 50(5):294-299. PubMed ID: 31266065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.
    Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M
    Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of tuberous sclerosis complex.
    Leclezio L; de Vries PJ
    Curr Opin Psychiatry; 2015 Mar; 28(2):113-20. PubMed ID: 25602245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Developmental and Behavioral Concerns in Toddlers With Tuberous Sclerosis Complex.
    McDonald NM; Jacobs S; Hyde C; Kasari C; Jeste SS
    Pediatr Neurol; 2024 Jun; 155():62-67. PubMed ID: 38603983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.
    Wilbur C; Sanguansermsri C; Chable H; Anghelina M; Peinhof S; Anderson K; Steinbok P; Singhal A; Datta A; Connolly MB
    Can J Neurol Sci; 2017 Jan; 44(1):35-43. PubMed ID: 28004629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ).
    Heunis TM; Chambers N; Vanclooster S; Bissell S; Byars AW; Capal JK; Cukier S; Davis PE; de Vries MC; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ
    Pediatr Neurol; 2023 Oct; 147():101-123. PubMed ID: 37598571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
    Słowińska M; Jóźwiak S; Peron A; Borkowska J; Chmielewski D; Sadowski K; Jurkiewicz E; Vignoli A; La Briola F; Canevini MP; Kotulska-Jóźwiak K
    Orphanet J Rare Dis; 2018 Jan; 13(1):25. PubMed ID: 29378663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist.
    Leclezio L; Jansen A; Whittemore VH; de Vries PJ
    Pediatr Neurol; 2015 Jan; 52(1):16-24. PubMed ID: 25499093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
    Curatolo P; Moavero R; de Vries PJ
    Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study.
    Moavero R; Voci A; La Briola F; Matricardi S; Toldo I; Mancardi MM; Negrin S; Messana T; Mazzone L; Valeriani M; Curatolo P; Bruni O
    Sleep Med; 2022 Jan; 89():65-70. PubMed ID: 34915263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.